Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Cleveland › NPI 1134348659
Physician

Camil I Kreit MD PA

Camil I Kreit MD PA was paid $175K by Medicaid between Jan 2018 and Nov 2024, across 16 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 80% of everything it billed.

33Billing provider infoCAMIL I KREIT MD PA
CLEVELAND, TX 77327
33aNPI1134348659assigned 04/24/2007
28Total paid$175K
24GClaims8,117
24DCodes billed16
24AFirst – last monthJan 2018 – Nov 2024
Box 24A · Dates of service

Paid by month

$0$2.5K$5.0K$7.5K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,633$7K
20191,152$5K
2020736$13K
20211,621$48K
20221,672$53K
2023824$34K
2024incomplete479$16K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 80% 4,871 4,027 $140K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 14% 880 784 $25K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 2.5% 625 591 $4K
99443 1.4% 57 54 $3K
99215 Doctor's office visit, returning patient (complex)Prolong outpt/office vis <1% 24 24 $2K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity <1% 14 12 $1K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 14 12 $331.04
99406 <1% 29 25 $191.28
90756 <1% 22 19 $175.77
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 378 361 $60.00
84311 <1% 389 373 $7.34
82570 <1% 375 359 $5.43
4 more codes
81003 <1% 400 $2.36
G0008 Administration of influenza virus vaccine 0% 13 $0.00
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 0% 12 $0.00
G0444 Annual depression screening, 5 to 15 minutes 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKREIT, CAMIL (PRESIDENT)